eplex sars-cov-2 diagnostic test (GenMark Diagnostics)
90
Structured Review
GenMark Diagnostics
eplex sars-cov-2 diagnostic test
Eplex Sars Cov 2 Diagnostic Test, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex+sars-cov-2+test/eplex+sars+cov+2+test/pm40386630-56-9-9
Average 90 stars, based on 1 article reviews
Eplex Sars Cov 2 Diagnostic Test, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex+sars-cov-2+test/eplex+sars+cov+2+test/pm40386630-56-9-9
Average 90 stars, based on 1 article reviews
eplex sars-cov-2 diagnostic test - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Reverse Transcription Polymerase Chain Reaction:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Cell Counting:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Infection:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Quantitative RT-PCR:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Multiplex Assay:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Fluorescence:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Virus:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Amplification:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the MicroChIP Assay:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Polymerase Chain Reaction:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Diagnostic Assay:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Enzyme-linked Immunosorbent Assay:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Luminex:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Real-time Polymerase Chain Reaction:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Sequencing:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Biomarker Discovery:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Magnetic Beads:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Selection:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Electrophoresis:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Variant Assay:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Conjugation Assay:Article Title: Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the Article Title: Saliva versus Upper Respiratory Swabs: Equivalent for Severe Acute Respiratory Syndrome Coronavirus 2 University Screening while Saliva Positivity Is Prolonged After Symptom Onset in Coronavirus Disease 2019 Hospitalized Patients. Article Snippet: PCR-based assays were used for testing AN specimens, according to the instructions for use: Article Title: Aptamers as promising nanotheranostic tools in the COVID ‐19 pandemic era Article Snippet: Article Title: Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence Article Snippet: Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations Article Snippet: For instance, the Article Title: Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Article Snippet: For instance, the Article Title: Saliva vs upper respiratory swabs: Equivalent for SARS-CoV-2 university screening while saliva positivity is prolonged post-symptom onset in COVID-19 hospitalized patients Article Snippet: The following EUA PCR-based assays were used for testing AN specimens according to the instructions for use (IFU): Article Title: Monocyte Distribution Width as a Pragmatic Diagnostic Screen for SARS-CoV-2 and Influenza Infection Article Snippet: For the diagnosis of SARS-CoV-2, a variety of RT-PCR platforms were utilized based on availability including the Xpert Xpress SARS-CoV-2 test (Cepheid, Sunnyvale, CA, USA), the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany), the NeuMoDx SARS-CoV-2 assay (NeuMoDx, Ann Arbor, MI, USA), SARS-CoV-2 reagents for the BD MAX System (Becton Dickinson, Sparks, MD, USA), and the |